Treatment of Chickenpox in Adults
Adults with chickenpox should receive oral acyclovir 800 mg five times daily for 5-7 days, initiated within 24 hours of rash onset for maximum benefit. 1, 2
Indications for Antiviral Treatment
All adults with chickenpox warrant antiviral therapy, as they are at substantially higher risk for severe complications compared to children. 1, 3 The key complications include:
- Pneumonitis (most common serious complication in adults) 4, 3
- Hepatitis and visceral dissemination 4, 3
- Hemorrhagic varicella 4
- Secondary bacterial skin infections 4, 5
- Central nervous system complications including encephalitis 4
Adults over 12 years of age are specifically identified as a high-risk group requiring antiviral therapy. 1
Standard Dosing Regimen
Oral acyclovir: 800 mg orally 4-5 times daily for 5-7 days 1, 2
- Treatment must be initiated within 24 hours of rash onset for optimal efficacy 1, 6
- Continue treatment for the full 5-7 day course even if symptoms improve 2
- The 800 mg dose is critical—lower doses (such as 400 mg) are inadequate for varicella-zoster virus infection 2
When to Escalate to Intravenous Therapy
Switch to IV acyclovir 10 mg/kg every 8 hours if: 1, 7
- Severe disease with extensive cutaneous involvement 7, 3
- Immunocompromised patients (on corticosteroids, chemotherapy, biologics, or other immunosuppressants) 1, 7
- Visceral complications (pneumonitis, hepatitis, encephalitis) 4, 7
- Inability to tolerate oral medications 3
- Hemorrhagic varicella 4
Continue IV therapy for 7-10 days and at least until all lesions have crusted over. 1, 7
Special Populations Requiring Aggressive Management
Immunocompromised patients: 1
- Immediately discontinue immunomodulator therapy during active chickenpox infection 1
- Do not commence or continue immunosuppressive therapy during active infection 1
- Start IV acyclovir 10 mg/kg every 8 hours immediately 1
- Immunomodulator therapy can only be reintroduced after all vesicles have crusted over and fever has resolved 1
Pregnant women: 6
- Oral acyclovir 800 mg five times daily for mild disease 6
- IV acyclovir for serious complications like pneumonia 6
Patients on chronic salicylate or corticosteroid therapy: 1
- Require antiviral therapy due to increased risk of Reye syndrome (salicylates) and severe disease (corticosteroids) 1
Post-Exposure Prophylaxis
For susceptible adults exposed to active chickenpox: 1
First-line: Varicella-Zoster Immune Globulin (VZIG) within 96 hours of exposure 8, 1
- Particularly critical for immunocompromised patients and pregnant women 8
- Cost is approximately $400 for adult dose 8
Alternative if VZIG unavailable: 8, 1
Renal Dose Adjustments
For patients with renal impairment, acyclovir dosing must be adjusted: 2
- CrCl >25 mL/min: 800 mg every 4 hours (5 times daily) 2
- CrCl 10-25 mL/min: 800 mg every 8 hours 2
- CrCl 0-10 mL/min: 800 mg every 12 hours 2
- Hemodialysis patients: Administer additional dose after each dialysis session 2
Maintain adequate hydration during therapy to prevent acyclovir crystalluria. 7
Adjunctive Therapy
Antibiotics only if secondary bacterial infection develops: 4, 5
Corticosteroids are NOT recommended and may worsen outcomes by increasing viral replication. 5
Infection Control
- Isolate patients until all lesions have crusted over 1
- Chickenpox remains contagious to susceptible individuals throughout the vesicular stage 6
- Healthcare workers exposed without immunity should be furloughed days 10-21 post-exposure 1
Critical Pitfalls to Avoid
- Never delay treatment waiting for laboratory confirmation—chickenpox is a clinical diagnosis and treatment efficacy drops dramatically after 24 hours 1, 6
- Never use inadequate dosing (e.g., 400 mg doses appropriate for herpes simplex are insufficient for varicella) 2
- Never continue immunosuppressive therapy during active chickenpox in severe cases—this substantially increases mortality risk 1
- Never assume immunity based on age alone—verify history or serology, as 30-35% of adults remain susceptible 1
- Never use topical acyclovir—it is substantially less effective than systemic therapy 7